Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), ...
A well-chosen triathlon watch can revolutionise your performance, making you train stronger, smarter and faster. But which ...
Your watch’s VO2 max isn’t perfect, but you can improve its accuracy with better data and heart-rate tracking.